{
  "catalogId": "7ccd87c0-2621-4240-afd6-d4175ac477cc",
  "name": "REBIF 22 MCG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "110 94 29437 06",
  "treatmentDescriptions": "Rebif (interferone beta-1a) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability. Efficacy of Rebif in chronic progressive multiple sclerosis has not been established.",
  "termsOfIssue": "Prescription required",
  "form": "solution for injection",
  "route": "s.c",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "INTERFERON BETA 1A/ML",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L03AB07",
      "name": "INTERFERON BETA-1A"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "REBIF 22MCG/0.5ML 12 SYRINGES",
      "manufacturer": {
        "name": "מרק סרונו",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 12.0,
        "unit": "units"
      },
      "packagingDescription": "CARTRIDGE GLASS TYPE I",
      "shelfLife": "18",
      "storageConditions": "",
      "codes": {
        "moh": "6117",
        "yarpa": "22663",
        "pharmasoft": "18322",
        "barcode": "7290000845265"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 2147.044253,
        "retailMargin": 10.0,
        "maxRetailPrice": 2361.748679,
        "maxPriceWithVAT": 2786.863317
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:43.645271"
  }
}